Categories
-
Adhesives
6
Amines
115
Amino Acids
210
Analytical Reagents
751
Antibiotics
275
Bioactive Small Molecules
806
Aroma Chemicals
247
Biochemicals
1158
Boronic Acids
4
Buffers
105
Building Blocks
2196
Carbohydrates
193
Catalysts
120
Chiral Compounds
77
Coccus nucifera oil
0
Detergents
63
Diagnostic Raw Materials
273
Flavours and Fragrance Materials
236
Fluorinated Products
68
Furans
7
Gases in Solution
53
Grignard Reagents
32
HPLC Reagents
8
Imidazoles
19
Indoles
48
Inorganic Chemicals
360
Ion-Pair Reagents
21
Ligands
81
Organics
1651
Oxazoles
3
Peptide Reagents
102
Phenols
55
Picolines
0
Piperazines
13
Pyrazines
3
Pyridines
69
Pyrimidines
36
Quaternary Ammonium salts
45
Reagents
114
Research Organics & Inorganics
895
Salts
311
Sealing Compounds
1
Sherclin
1
Solvents
134
Stains & Indicators
324
Sugars
67
Tailor-made solutions
1
Testing Standards
4
Uncategorised
23
Water Analysis
12
Heparin lithium salt
(36120358 | 9045-22-1)
| CAS: | 9045-22-1 |
|---|---|
| Molecular Formula: | N/A |
| Molecular Weight: | N/A |
| Availablility: | In Stock |
|---|---|
| Downloads: | Product Specification | Safety Data Sheet [EN] |
| 36120358-1g | 1g | £124.50 | |
| Bulk Order | |||
| 36120358-1g | 1g | €174.30 | |
| Bulk Order | |||
| 36120358-1g | 1g | $186.80 | |
| Bulk Order | |||
Safety Data Sheet
Certificate of Analysis
Product Detail
| Product Code | 36120358 | ||||
| Product Name | Heparin lithium salt | ||||
| Categories | Bioactive Small Molecules Research Organics & Inorganics | ||||
| CAS | 9045-22-1 | ||||
| Molecular Formula | N/A | ||||
| Molecular Weight | N/A | ||||
| Storage Details | Ambient | ||||
| Harmonised Tariff Code | 30019091 |
Product Specification
| Heavy metals | ≤30PPM | ||||
| pH | 5.0-7.5 | ||||
| Loss on Drying | ≤8.0% | ||||
| Assay | ≥150.0U/mg(Dry) | ||||
| Optical Rotation | ≥＋32 | ||||
| Appearance | White or almost white powder, moderately hygroscopic | ||||
| Origin | Porcine intestinal mucosa |
Safety Information
| Pictograms |
|
||||
| Signal word | danger | ||||
| Hazard statements |
|
||||
| Precautionary statements |
|